abrdn Life Sciences Investors: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of abrdn Life Sciences Investors, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €88.6m. The latest transaction was reported on 22 May 2025 (Cession). Among the most active insiders: Saba Capital Management, L.P.. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 22 May 2025
All Executives45 Thresholds0 Prospectus0 Other0
Declarations 45 total
11,419 shares @ US$12.71 1.3% of flow Common Stock SEC:0001510281-25-000325:0
23,729 shares @ US$12.08 2.7% of flow Common Stock SEC:0001510281-25-000315:0
730 shares @ US$12.28 0.1% of flow Common Stock SEC:0001510281-25-000308:0
12,689 shares @ US$11.98 1.4% of flow Common Stock SEC:0001510281-25-000291:0
1,366 shares @ US$12.19 0.2% of flow Common Stock SEC:0001510281-25-000287:0
9,144 shares @ US$11.78 1.0% of flow Common Stock SEC:0001510281-25-000226:0
1,700 shares @ US$11.92 0.2% of flow Common Stock SEC:0001510281-25-000219:0
15,400 shares @ US$11.67 1.6% of flow Common Stock SEC:0001510281-25-000211:0
30,156 shares @ US$11.14 3.1% of flow Common Stock SEC:0001510281-25-000204:0
10,321 shares @ US$12.23 1.2% of flow Common Stock SEC:0001510281-25-000186:0
17,621 shares @ US$12.45 2.1% of flow Common Stock SEC:0001510281-25-000178:0
48,623 shares @ US$12.58 5.9% of flow Common Stock SEC:0001510281-25-000176:0
32,922 shares @ US$13.01 4.1% of flow Common Stock SEC:0001510281-25-000174:0
2,329 shares @ US$13.21 0.3% of flow Common Stock SEC:0001510281-25-000167:0
200 shares @ US$13.62 0.0% of flow Common Stock SEC:0001510281-25-000113:0
100 shares @ US$13.88 0.0% of flow Common Stock SEC:0001510281-25-000095:0
36,536 shares @ US$13.75 5.0% of flow Common Stock SEC:0001510281-25-000090:0
42,987 shares @ US$13.95 6.0% of flow Common Stock SEC:0001510281-25-000085:0
1,846 shares @ US$14.03 0.3% of flow Common Stock SEC:0001510281-25-000072:0
21,835 shares @ US$14.16 3.1% of flow Common Stock SEC:0001510281-25-000066:0
11,674 shares @ US$14.12 1.6% of flow Common Stock SEC:0001510281-25-000058:0
▲ Director · Executives · 23 Aug 2024
650 shares @ US$15.37 42.4% of flow Common Stock SEC:0001104659-24-093318:0
Ideal exit: 20 May 2025 (T+270) ▲ Director · Executives · 16 Jul 2024
1,000 shares @ US$15.53 100.0% of flow Common Stock SEC:0001104659-24-080798:0
Ideal exit: 12 Apr 2025 (T+270) 100 shares @ US$14.07 0.0% of flow Common Stock SEC:0001510281-24-000343:0
Ideal exit: 23 Mar 2025 (T+270) 13,812 shares @ US$14.08 1.9% of flow Common Stock SEC:0001510281-24-000338:0
Ideal exit: 21 Mar 2025 (T+270) 25 of 45 declarations
Load more (20 remaining)